C/O Precision Biosciences, Inc., 302 East Pettigrew Street, Suite A 100, Durham, NC
Summary
The estimated net worth of R. Matthew Kane is at least $749K dollars as of June 9, 2021. R. Matthew Kane is the President and CEO, Director of PRECISION BIOSCIENCES INC and owns shares of PRECISION BIOSCIENCES INC (DTIL) stock worth about $749K.
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Matthew Kane
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.